2008

All Categories

Archive

Date Title Document
Biovail Announces Voluntary Recall of Certain Lots of Ultram(R) ER 100mg Tablets Date 12/30/08 Title Biovail Announces Voluntary Recall of Certain Lots of Ultram(R) ER 100mg Tablets Download PDF
Biovail Announces Litigation Settlement Date 12/23/08 Title Biovail Announces Litigation Settlement Download PDF
Biovail Enters into Commercial Alliance for Aplenzin(TM) Date 12/22/08 Title Biovail Enters into Commercial Alliance for Aplenzin(TM) Download PDF
Biovail to Present at Natixis Bleichroeder Hidden Gems Conference Date 12/07/08 Title Biovail to Present at Natixis Bleichroeder Hidden Gems Conference Download PDF
Biovail Announces Filing of ANDA for Quetiapine XR Tablets Date 12/01/08 Title Biovail Announces Filing of ANDA for Quetiapine XR Tablets Download PDF
Biovail Announces U.S. Availability of Xenazine(R) Tablets Date 11/24/08 Title Biovail Announces U.S. Availability of Xenazine(R) Tablets Download PDF
Biovail to Participate at Upcoming Conferences Date 11/11/08 Title Biovail to Participate at Upcoming Conferences Download PDF
Biovail Reports Third-Quarter 2008 Financial Results Date 11/06/08 Title Biovail Reports Third-Quarter 2008 Financial Results Download PDF
Biovail Declares Quarterly Dividend Date 11/06/08 Title Biovail Declares Quarterly Dividend Download PDF
Biovail Appoints Dr. H. Christian Fibiger Senior Vice-President, Chief Scientific Officer Date 11/06/08 Title Biovail Appoints Dr. H. Christian Fibiger Senior Vice-President, Chief Scientific Officer Download PDF
Biovail Announces Third-Quarter 2008 Earnings Release, Conference-Call Details Date 10/28/08 Title Biovail Announces Third-Quarter 2008 Earnings Release, Conference-Call Details Download PDF
Biovail Comments on Filing of Lawsuit Date 10/09/08 Title Biovail Comments on Filing of Lawsuit Download PDF
Biovail to Participate at Upcoming Investor Conferences Date 09/18/08 Title Biovail to Participate at Upcoming Investor Conferences Download PDF
Biovail Acquires Prestwick Pharmaceuticals Date 09/17/08 Title Biovail Acquires Prestwick Pharmaceuticals Download PDF
Biovail Announces Filing of ANDA for Fenofibrate Tablets Date 09/03/08 Title Biovail Announces Filing of ANDA for Fenofibrate Tablets Download PDF
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain Date 08/25/08 Title Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain Download PDF
Biovail Appoints Peggy Mulligan Chief Financial Officer Date 08/21/08 Title Biovail Appoints Peggy Mulligan Chief Financial Officer Download PDF
Biovail Appoints Dr. Neil M. Sussman Vice-President, Neurologic & Psychiatric Development Date 08/20/08 Title Biovail Appoints Dr. Neil M. Sussman Vice-President, Neurologic & Psychiatric Development Download PDF
Biovail Reports Second-Quarter 2008 Financial Results Date 08/13/08 Title Biovail Reports Second-Quarter 2008 Financial Results Download PDF
Biovail Declares Quarterly Dividend Date 08/12/08 Title Biovail Declares Quarterly Dividend Download PDF
Biovail Shareholders Confirm Election of Company Board Nominees Date 08/08/08 Title Biovail Shareholders Confirm Election of Company Board Nominees Download PDF
Biovail Waives Proxy Voting Cut-Off Date 08/06/08 Title Biovail Waives Proxy Voting Cut-Off Download PDF
Biovail Announces Second-Quarter 2008 Earnings Release, Conference-Call Details Date 07/30/08 Title Biovail Announces Second-Quarter 2008 Earnings Release, Conference-Call Details Download PDF
Biovail Reminds Shareholders to Vote FOR the Biovail Nominees Using BLUE Proxy Date 07/29/08 Title Biovail Reminds Shareholders to Vote FOR the Biovail Nominees Using BLUE Proxy Download PDF
Biovail to Reconvene Annual Meeting on August 8, 2008 Date 07/21/08 Title Biovail to Reconvene Annual Meeting on August 8, 2008 Download PDF
Biovail to Reconvene Annual Meeting of Shareholders as Soon as Reasonably Possible Date 07/16/08 Title Biovail to Reconvene Annual Meeting of Shareholders as Soon as Reasonably Possible Download PDF
Biovail Comments on Eugene Melnyk's Continued Distortion of the Facts Date 06/25/08 Title Biovail Comments on Eugene Melnyk's Continued Distortion of the Facts Download PDF
Biovail Provides Shareholders With Additional Analyst Commentary Date 06/20/08 Title Biovail Provides Shareholders With Additional Analyst Commentary Download PDF
Biovail Reminds Shareholders of Deadline for Decision on the Future of Their Company Date 06/19/08 Title Biovail Reminds Shareholders of Deadline for Decision on the Future of Their Company Download PDF
Biovail Comments on Glass Lewis Report Date 06/19/08 Title Biovail Comments on Glass Lewis Report Download PDF
Biovail Announces That a Second Proxy Advisory Firm Recommends Shareholders Vote for Biovail's Director Nominees Date 06/18/08 Title Biovail Announces That a Second Proxy Advisory Firm Recommends Shareholders Vote for Biovail's Director Nominees Download PDF
Biovail Dismisses Inappropriate and Unnecessary Debate Date 06/17/08 Title Biovail Dismisses Inappropriate and Unnecessary Debate Download PDF
Biovail Announces Mailing and Filing of Management Proxy Circular Date 06/16/08 Title Biovail Announces Mailing and Filing of Management Proxy Circular Download PDF
REPEAT/Biovail Announces That RiskMetrics Group Recommends Shareholders Vote ''For'' Biovail's Director Nominees Date 06/16/08 Title REPEAT/Biovail Announces That RiskMetrics Group Recommends Shareholders Vote ''For'' Biovail's Director Nominees Download PDF
Biovail CEO Bill Wells BNN Interview Available on Company Website Date 06/16/08 Title Biovail CEO Bill Wells BNN Interview Available on Company Website Download PDF
Biovail Recommends Shareholders Vote to Move Forward from the Melnyk Lost Years Date 06/16/08 Title Biovail Recommends Shareholders Vote to Move Forward from the Melnyk Lost Years Download PDF
Biovail Announces That RiskMetrics Group Recommends Shareholders Vote ''For'' Biovail's Director Nominees Date 06/14/08 Title Biovail Announces That RiskMetrics Group Recommends Shareholders Vote ''For'' Biovail's Director Nominees Download PDF
Biovail Provides Update on Share Repurchase Program Date 06/13/08 Title Biovail Provides Update on Share Repurchase Program Download PDF
Biovail to Present at 2008 Goldman Sachs Global Healthcare Conference Date 06/10/08 Title Biovail to Present at 2008 Goldman Sachs Global Healthcare Conference Download PDF
Biovail Shareholders Should Disregard the Latest Misinformation from Eugene Melnyk Date 06/09/08 Title Biovail Shareholders Should Disregard the Latest Misinformation from Eugene Melnyk Download PDF
Biovail Responds to Dissident Circular Date 06/05/08 Title Biovail Responds to Dissident Circular Download PDF
Biovail Notes Filing of Dissident Circular Date 06/03/08 Title Biovail Notes Filing of Dissident Circular Download PDF
Biovail Launches Normal Course Issuer Bid Date 05/27/08 Title Biovail Launches Normal Course Issuer Bid Download PDF
Biovail Subsidiary Reaches Settlement with United States Department of Justice Date 05/16/08 Title Biovail Subsidiary Reaches Settlement with United States Department of Justice Download PDF
Biovail to Present at 2008 Citi Investment Research Global Healthcare Conference Date 05/13/08 Title Biovail to Present at 2008 Citi Investment Research Global Healthcare Conference Download PDF
Biovail Declares Quarterly Dividend Date 05/08/08 Title Biovail Declares Quarterly Dividend Download PDF
Biovail Reports First-Quarter 2008 Financial Results Date 05/08/08 Title Biovail Reports First-Quarter 2008 Financial Results Download PDF
Biovail Announces Normal Course Issuer Bid Date 05/08/08 Title Biovail Announces Normal Course Issuer Bid Download PDF
Biovail Announces New Strategic Focus Date 05/08/08 Title Biovail Announces New Strategic Focus Download PDF
Biovail Announces First-Quarter 2008 Earnings Release, Conference-Call Details Date 04/28/08 Title Biovail Announces First-Quarter 2008 Earnings Release, Conference-Call Details Download PDF
Biovail Settles Canadian Securities Class-Action Litigation Date 04/23/08 Title Biovail Settles Canadian Securities Class-Action Litigation Download PDF
Biovail Receives FDA Approval for Aplenzin (BVF-033) Date 04/23/08 Title Biovail Receives FDA Approval for Aplenzin (BVF-033) Download PDF
Biovail Announces Changes to Board Committees Date 04/21/08 Title Biovail Announces Changes to Board Committees Download PDF
Biovail Strengthens Leadership Team Date 04/21/08 Title Biovail Strengthens Leadership Team Download PDF
Biovail Announces Resignation of Director Bill Bristow Date 04/21/08 Title Biovail Announces Resignation of Director Bill Bristow Download PDF
Biovail Announces Withdrawal of Legal Action by Eugene Melnyk Date 04/10/08 Title Biovail Announces Withdrawal of Legal Action by Eugene Melnyk Download PDF
Biovail Announces Resignation of Director Jamie Sokalsky Date 03/28/08 Title Biovail Announces Resignation of Director Jamie Sokalsky Download PDF
Biovail Reaches Settlement With SEC, Provides Update On OSC Investigation Date 03/24/08 Title Biovail Reaches Settlement With SEC, Provides Update On OSC Investigation Download PDF
Biovail Declares Quarterly Dividend Date 03/13/08 Title Biovail Declares Quarterly Dividend Download PDF
Biovail Reports Fourth Quarter and Year-End 2007 Financial Results, Provides Strategy Update Date 03/13/08 Title Biovail Reports Fourth Quarter and Year-End 2007 Financial Results, Provides Strategy Update Download PDF
Biovail Announces Fourth-Quarter, Full-Year 2007 Earnings Release, Conference-Call Details Date 03/07/08 Title Biovail Announces Fourth-Quarter, Full-Year 2007 Earnings Release, Conference-Call Details Download PDF
Biovail Announces Change in Board of Directors Date 02/27/08 Title Biovail Announces Change in Board of Directors Download PDF
Biovail Receives Canadian Approval for Wellbutrin(R) XL for the Prevention of Seasonal Major Depressive Illness Date 02/15/08 Title Biovail Receives Canadian Approval for Wellbutrin(R) XL for the Prevention of Seasonal Major Depressive Illness Download PDF
Biovail to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference Date 02/04/08 Title Biovail to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference Download PDF
Biovail Receives Letter Related to 2003 Cardizem(R) LA Launch Activities from U.S. Attorney's Office Date 02/01/08 Title Biovail Receives Letter Related to 2003 Cardizem(R) LA Launch Activities from U.S. Attorney's Office Download PDF
Biovail Announces Canadian Commercial Availability of 1,000mg Dosage of Glumetza(TM) Date 01/24/08 Title Biovail Announces Canadian Commercial Availability of 1,000mg Dosage of Glumetza(TM) Download PDF
Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol Date 01/02/08 Title Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol Download PDF
Powered by Sitecore